Foundry Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-131,885
| Closed | -$6.07M | – | 450 |
|
|
2016
Q3 | $6.07M | Sell |
131,885
-74,707
| -36% | -$3.44M | 0.32% | 113 |
|
|
2016
Q2 | $10.4M | Sell |
206,592
-22,265
| -10% | -$1.12M | 0.59% | 42 |
|
|
2016
Q1 | $12.2M | Buy |
228,857
+14,715
| +7% | +$787K | 1.21% | 19 |
|
|
2015
Q4 | $14.1M | Sell |
214,142
-3,045
| -1% | -$200K | 1.17% | 20 |
|
|
2015
Q3 | $12.3M | Sell |
217,187
-64,730
| -23% | -$3.65M | 1.07% | 22 |
|
|
2015
Q2 | $16.7M | Buy |
281,917
+18,916
| +7% | +$1.12M | 1.33% | 11 |
|
|
2015
Q1 | $16.4M | Buy |
263,001
+47,211
| +22% | +$2.94M | 1.36% | 10 |
|
|
2014
Q4 | $12.4M | Buy |
215,790
+76,121
| +55% | +$4.38M | 1.02% | 29 |
|
|
2014
Q3 | $7.51M | Buy |
139,669
+25,215
| +22% | +$1.36M | 0.7% | 57 |
|
|
2014
Q2 | $6M | Sell |
114,454
-4,208
| -4% | -$221K | 0.56% | 83 |
|
|
2014
Q1 | $6.27M | Sell |
118,662
-5,456
| -4% | -$288K | 0.59% | 74 |
|
|
2013
Q4 | $4.98M | Buy |
+124,118
| New | +$4.98M | 0.45% | 87 |
|